Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study

Abayomi Oyenuga; Aaron R Folsom; Oluwaseun Fashanu; David Aguilar; Christie M. Ballantyne

doi:10.1177/0003319718780772

Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study

Abayomi Oyenuga, Aaron R Folsom, Oluwaseun Fashanu, David Aguilar, Christie M. Ballantyne

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Galectin-3 is a β-galactoside-binding lectin that plays a role in the regulation of several conditions that are associated with atherosclerosis. The goal of this cross-sectional study was to assess the association of plasma galectin-3 concentrations with sonographic measures of carotid atherosclerosis in the Atherosclerosis Risk in Communities study. Linear regression was used to determine the difference and 95% confidence intervals (CIs) for carotid intima–media thickness (cIMT) by categorical and continuous representations of galectin-3. Logistic regression was used to determine the odds ratio and 95% CI, separately, for dichotomized cIMT (75th percentile = 0.9 mm) and carotid plaque and/or shadowing. Compared to those in the first quintile of galectin-3, those in the fifth quintile of galectin-3 level had higher cIMT (mean difference: 0.020 mm after multivariable adjustment; P trend =.04). Moreover, compared to those in the lowest galectin-3 quintile, those in the highest galectin-3 quintile had higher odds of carotid plaque/and or shadowing (odds ratio 1.13 after multivariable adjustment; P trend =.014). Higher levels of galectin-3 are associated with greater carotid atherosclerosis. Our findings provide support for the role of inflammatory biomarkers in the pathogenesis of atherosclerosis and suggest galectin-3 as a possible target for intervention in the prevention or management of atherosclerotic disease.

Original language	English (US)
Pages (from-to)	47-55
Number of pages	9
Journal	Angiology
Volume	70
Issue number	1
DOIs	https://doi.org/10.1177/0003319718780772
State	Published - Jan 1 2019

Bibliographical note

Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract nos HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I. Christie M. Ballantyne received grant/ research support from Abbott Diagnostics and Roche Diagnostics (to institution, not individual). Abbott Diagnostics provided funding for the galectin-3 measurements.

Publisher Copyright:
© The Author(s) 2018.

Keywords

ARIC
atherosclerosis
carotid intima–media thickness
galectin-3
plaque
shadowing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1177/0003319718780772

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239970

OpenUrl availability

Full text

Cite this

@article{6474604ca3df48af995c9ccabc07d484,

title = "Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study",

abstract = "Galectin-3 is a β-galactoside-binding lectin that plays a role in the regulation of several conditions that are associated with atherosclerosis. The goal of this cross-sectional study was to assess the association of plasma galectin-3 concentrations with sonographic measures of carotid atherosclerosis in the Atherosclerosis Risk in Communities study. Linear regression was used to determine the difference and 95% confidence intervals (CIs) for carotid intima–media thickness (cIMT) by categorical and continuous representations of galectin-3. Logistic regression was used to determine the odds ratio and 95% CI, separately, for dichotomized cIMT (75th percentile = 0.9 mm) and carotid plaque and/or shadowing. Compared to those in the first quintile of galectin-3, those in the fifth quintile of galectin-3 level had higher cIMT (mean difference: 0.020 mm after multivariable adjustment; P trend =.04). Moreover, compared to those in the lowest galectin-3 quintile, those in the highest galectin-3 quintile had higher odds of carotid plaque/and or shadowing (odds ratio 1.13 after multivariable adjustment; P trend =.014). Higher levels of galectin-3 are associated with greater carotid atherosclerosis. Our findings provide support for the role of inflammatory biomarkers in the pathogenesis of atherosclerosis and suggest galectin-3 as a possible target for intervention in the prevention or management of atherosclerotic disease.",

keywords = "ARIC, atherosclerosis, carotid intima–media thickness, galectin-3, plaque, shadowing",

author = "Abayomi Oyenuga and Folsom, {Aaron R} and Oluwaseun Fashanu and David Aguilar and Ballantyne, {Christie M.}",

note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract nos HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I. Christie M. Ballantyne received grant/ research support from Abbott Diagnostics and Roche Diagnostics (to institution, not individual). Abbott Diagnostics provided funding for the galectin-3 measurements. Publisher Copyright: {\textcopyright} The Author(s) 2018.",

year = "2019",

month = jan,

day = "1",

doi = "10.1177/0003319718780772",

language = "English (US)",

volume = "70",

pages = "47--55",

journal = "Angiology",

issn = "0003-3197",

publisher = "SAGE Publications Inc.",

number = "1",

}

TY - JOUR

T1 - Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study

AU - Oyenuga, Abayomi

AU - Folsom, Aaron R

AU - Fashanu, Oluwaseun

AU - Aguilar, David

AU - Ballantyne, Christie M.

N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract nos HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I. Christie M. Ballantyne received grant/ research support from Abbott Diagnostics and Roche Diagnostics (to institution, not individual). Abbott Diagnostics provided funding for the galectin-3 measurements. Publisher Copyright: © The Author(s) 2018.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Galectin-3 is a β-galactoside-binding lectin that plays a role in the regulation of several conditions that are associated with atherosclerosis. The goal of this cross-sectional study was to assess the association of plasma galectin-3 concentrations with sonographic measures of carotid atherosclerosis in the Atherosclerosis Risk in Communities study. Linear regression was used to determine the difference and 95% confidence intervals (CIs) for carotid intima–media thickness (cIMT) by categorical and continuous representations of galectin-3. Logistic regression was used to determine the odds ratio and 95% CI, separately, for dichotomized cIMT (75th percentile = 0.9 mm) and carotid plaque and/or shadowing. Compared to those in the first quintile of galectin-3, those in the fifth quintile of galectin-3 level had higher cIMT (mean difference: 0.020 mm after multivariable adjustment; P trend =.04). Moreover, compared to those in the lowest galectin-3 quintile, those in the highest galectin-3 quintile had higher odds of carotid plaque/and or shadowing (odds ratio 1.13 after multivariable adjustment; P trend =.014). Higher levels of galectin-3 are associated with greater carotid atherosclerosis. Our findings provide support for the role of inflammatory biomarkers in the pathogenesis of atherosclerosis and suggest galectin-3 as a possible target for intervention in the prevention or management of atherosclerotic disease.

AB - Galectin-3 is a β-galactoside-binding lectin that plays a role in the regulation of several conditions that are associated with atherosclerosis. The goal of this cross-sectional study was to assess the association of plasma galectin-3 concentrations with sonographic measures of carotid atherosclerosis in the Atherosclerosis Risk in Communities study. Linear regression was used to determine the difference and 95% confidence intervals (CIs) for carotid intima–media thickness (cIMT) by categorical and continuous representations of galectin-3. Logistic regression was used to determine the odds ratio and 95% CI, separately, for dichotomized cIMT (75th percentile = 0.9 mm) and carotid plaque and/or shadowing. Compared to those in the first quintile of galectin-3, those in the fifth quintile of galectin-3 level had higher cIMT (mean difference: 0.020 mm after multivariable adjustment; P trend =.04). Moreover, compared to those in the lowest galectin-3 quintile, those in the highest galectin-3 quintile had higher odds of carotid plaque/and or shadowing (odds ratio 1.13 after multivariable adjustment; P trend =.014). Higher levels of galectin-3 are associated with greater carotid atherosclerosis. Our findings provide support for the role of inflammatory biomarkers in the pathogenesis of atherosclerosis and suggest galectin-3 as a possible target for intervention in the prevention or management of atherosclerotic disease.

KW - ARIC

KW - atherosclerosis

KW - carotid intima–media thickness

KW - galectin-3

KW - plaque

KW - shadowing

UR - http://www.scopus.com/inward/record.url?scp=85048294980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048294980&partnerID=8YFLogxK

U2 - 10.1177/0003319718780772

DO - 10.1177/0003319718780772

M3 - Article

C2 - 29879846

AN - SCOPUS:85048294980

SN - 0003-3197

VL - 70

SP - 47

EP - 55

JO - Angiology

JF - Angiology

IS - 1

ER -

Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this